Login to Your Account

Led By Aranesp, Enbrel Sales, Amgen's Q1 Earnings Strong

By Karen Pihl-Carey

Monday, April 26, 2004
Exceeding consensus estimates, Amgen Inc.'s first-quarter results showed strong sales that analysts said leave the company poised for near-term growth. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription